VanEck Biotech ETF (BBH) Short Interest Ratio & Short Volume → The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad) Free BBH Stock Alerts $151.99 -1.01 (-0.66%) (As of 04/18/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial MediaStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial Media VanEck Biotech ETF Short Interest DataCurrent Short Volume7,800 sharesPrevious Short Volume2,500 sharesChange Vs. Previous Month+212.00%Dollar Volume Sold Short$1.30 millionShort Interest Ratio / Days to Cover0.9Last Record DateMarch 31, 2024Outstanding Shares2,700,000 sharesPercentage of Shares Shorted0.29%Today's Trading Volume3,572 sharesAverage Trading Volume8,716 sharesToday's Volume Vs. Average41% Short Selling VanEck Biotech ETF ? Sign up to receive the latest short interest report for VanEck Biotech ETF and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatBBH Short Interest Over TimeBBH Days to Cover Over TimeBBH Percentage of Float Shorted Over Time Ad DTIBiden’s $374B Giveaway Into This SectorBiden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right hereClick here for the full story VanEck Biotech ETF Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/20247,800 shares $1.30 million +212.0%N/A0.9 $166.33 3/15/20242,500 shares $407,950.00 +25.0%N/A0.3 $163.18 2/29/20242,000 shares $325,480.00 +185.7%N/A0.2 $162.74 2/15/2024700 shares $114,422.00 -22.2%N/A0.1 $163.46 1/31/2024900 shares $148,950.00 -87.3%N/A0.1 $165.50 1/15/20247,100 shares $1.20 million +97.2%N/A0.5 $168.38 Get the Latest News and Ratings for BBH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for VanEck Biotech ETF and its competitors with MarketBeat's FREE daily newsletter. 12/31/20233,600 shares $595,116.00 -62.5%N/A0.3 $165.31 12/15/20239,600 shares $1.56 million -43.2%N/A0.8 $162.42 11/30/202316,900 shares $2.56 million +122.4%N/A1.8 $151.70 11/15/20237,600 shares $1.14 million +7.0%N/A1 $150.53 10/31/20237,100 shares $1.03 million -17.4%N/A1 $144.38 10/15/20238,600 shares $1.35 million +53.6%N/A1.2 $156.83 9/30/20235,600 shares $872,088.00 No ChangeN/A0.9 $155.73 9/15/20235,600 shares $897,344.00 -9.7%N/A0.8 $160.24 8/31/20236,200 shares $1.01 million +82.4%N/A1 $163.61 8/15/20233,400 shares $551,820.00 +70.0%N/A0.5 $162.30 7/31/20232,000 shares $321,560.00 -23.1%N/A0.3 $160.78 7/15/20232,600 shares $409,292.00 +8.3%N/A0.4 $157.42 6/30/20232,400 shares $374,520.00 -7.7%N/A0.4 $156.05 6/15/20232,600 shares $420,394.00 -13.3%N/A0.4 $161.69 5/31/20233,000 shares $463,890.00 No ChangeN/A0.4 $154.63 5/15/20233,000 shares $483,960.00 -52.4%N/A0.4 $161.32 4/30/20236,300 shares $1.01 million +14.6%N/A0.7 $159.73 4/15/20235,500 shares $913,165.00 +22.2%N/A0.5 $166.03 3/31/20234,500 shares $729,405.00 +95.7%N/A0.4 $162.09 3/15/20232,300 shares $360,479.00 +4.6%N/A0.2 $156.73 2/28/20232,200 shares $343,838.00 -74.1%N/A0.2 $156.29 2/15/20238,500 shares $1.40 million -38.0%N/A0.7 $164.77 1/31/202313,700 shares $2.30 million -38.6%N/A1 $167.74 1/15/202322,300 shares $3.75 million -9.0%N/A1.6 $168.27 12/30/202224,500 shares $3.91 million -9.9%N/A1.9 $159.74 12/15/202227,200 shares $4.51 million +115.9%N/A2 $165.75 11/30/202212,600 shares $2.12 million +106.6%N/A1 $168.16 11/15/20226,100 shares $1.02 million -80.7%N/A0.5 $166.95 10/31/202231,600 shares $4.97 million +182.1%N/A2.4 $157.23 10/15/202211,200 shares $1.63 million No ChangeN/A0.8 $145.46 9/30/20227,500 shares $1.06 million -33.6%N/A0.5 $140.78 9/15/202211,300 shares $1.67 million +41.3%N/A0.7 $147.60 8/31/20228,000 shares $1.17 million -7.0%N/A0.4 $145.98 8/15/20228,600 shares $1.41 million -1.2%N/A0.4 $163.51The “Perfect Storm” for Gold (Ad)Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.Click here now to download the free Precious Metals Buying Guide! BBH Short Interest - Frequently Asked Questions What is VanEck Biotech ETF's current short interest? Short interest is the volume of VanEck Biotech ETF shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 7,800 shares of BBH short. Learn More on VanEck Biotech ETF's current short interest. What is a good short interest ratio for VanEck Biotech ETF? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BBH shares currently have a short interest ratio of 1.0. Learn More on VanEck Biotech ETF's short interest ratio. Is VanEck Biotech ETF's short interest increasing or decreasing? VanEck Biotech ETF saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 7,800 shares, an increase of 212.0% from the previous total of 2,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does VanEck Biotech ETF's short interest compare to its competitors? Here is how the short interest of companies compare to VanEck Biotech ETF: VanEck Pharmaceutical ETF (0.14%), Invesco S&P SmallCap Health Care ETF (0.00%), ProShares Ultra Nasdaq Biotechnology (0.77%), Principal Healthcare Innovators ETF (0.32%), Invesco Nasdaq Biotechnology ETF (0.56%), First Trust Nasdaq Pharmaceuticals ETF (0.13%), JPMorgan Healthcare Leaders ETF (0.07%), ProShares UltraShort Nasdaq Biotechnology (8.77%), and iShares Biotechnology ETF (15.89%). Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short VanEck Biotech ETF stock? Short selling BBH is an investing strategy that aims to generate trading profit from VanEck Biotech ETF as its price is falling. BBH shares are trading down $1.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against VanEck Biotech ETF? A short squeeze for VanEck Biotech ETF occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BBH, which in turn drives the price of the stock up even further. How often is VanEck Biotech ETF's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BBH, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: VanEck Pharmaceutical ETF Short Squeeze Invesco S&P SmallCap Health Care ETF Short Squeeze ProShares Ultra Nasdaq Biotechnology Short Squeeze Principal Healthcare Innovators ETF Short Squeeze Invesco Nasdaq Biotechnology ETF Short Squeeze First Trust Nasdaq Pharmaceuticals ETF Short Squeeze JPMorgan Healthcare Leaders ETF Short Squeeze ProShares UltraShort Nasdaq Biotechnology Short Squeeze iShares Biotechnology ETF Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BBH) was last updated on 4/18/2024 by MarketBeat.com Staff From Our Partners[Urgent!] Generational Wealth GameplanCrypto 101 MediaBiden’s $374B Giveaway Into This SectorDTIBiden replacement revealed?Paradigm PressDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe Next Nvidia?InvestorPlaceHow Biden has already won 2024Porter & CompanyOptions trading has suddenly become more reliable.Eagle Publishing1970’s computer coder issues shocking A.I. warningTradeSmith